One of the aspects our teams do really well at Trial Runners is getting a study up and running fast. We average about 55 days to first patient enrolled after the clinical protocol is finalized. Executing a successful study start-up quickly is an essential first step in the life cycle of a clinical research trial and lots of credit goes to our ability to work with Central IRBs. Being able to utilize a Central IRB can save weeks and sometimes months to the start-up process.
Author: Patrick Healy
As a premier ophthalmology CRO, our expertise does not fall short on just the field of ocular indications. Some afflictions of the eye constitute as a rare disease such as Friedrich’s Ataxia and Alport Syndrome. Trial Runners has expanded its services to help the rare disease and orphan drug industry to bring comfort and hope to patients suffering from a rare indication.